Edition:
United Kingdom

Forward Pharma A/S (FWP.OQ)

FWP.OQ on NASDAQ Stock Exchange Global Select Market

2.92USD
23 Feb 2018
Change (% chg)

$-0.11 (-3.63%)
Prev Close
$3.03
Open
$3.03
Day's High
$3.03
Day's Low
$2.86
Volume
1,302
Avg. Vol
13,573
52-wk High
$30.44
52-wk Low
$2.76

Chart for

About

Forward Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in the development of FP187, a formulation of dimethyl fumarate (DMF) for the treatment of several inflammatory and neurological indications, including multiple sclerosis (MS). The Company's clinical candidate, FP187, is under development... (more)

Overall

Beta: --
Market Cap(Mil.): $301.51
Shares Outstanding(Mil.): 23.59
Dividend: 23.12
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Forward Pharma Says ‍European Patent Office Has Revoked EP2801355 Patent

* FORWARD PHARMA ANNOUNCES THE DECISION OF THE EUROPEAN PATENT OFFICE IN THE OPPOSITION PROCEEDINGS FOR THE EP2801355 PATENT

29 Jan 2018

BRIEF-Forward Pharma Files Further Written Submissions In European Opposition Proceeding For EP2801355 Patent

* FORWARD PHARMA FILES FURTHER WRITTEN SUBMISSIONS IN THE EUROPEAN OPPOSITION PROCEEDING FOR THE EP2801355 PATENT IN PREPARATION FOR THE ORAL HEARING IN JANUARY 2018

29 Nov 2017

BRIEF-Forward Pharma announces completion of corporate restructuring plan

* Forward Pharma announces completion of corporate restructuring plan Source text for Eikon: Further company coverage:

22 Nov 2017

BRIEF-Forward Pharma board approves capital reduction

* Forward Pharma board of directors approves capital reduction and returns EUR 917.7 million to shareholders

01 Sep 2017

Earnings vs. Estimates